Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020

造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル

◆タイトル:Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020
◆商品コード:MAM-MD-3577
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年7月6日
◆ページ数:165
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、造影剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、製品別分析、処置別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

Over the years, the contrast media/contrast agents market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide. These advancements have led to the improved use of many existing contrast agents as well as the introduction of new ones.

In 2015, the iodinated contrast media/contrast agents are expected to account for the largest share of the global contrast media/contrast agents market, among products; the injectable contrast media segment is expected to account for the largest share of the global contrast media/contrast agents market, among the routes of administration; the X-ray/CT segment is expected to dominate the global contrast media/contrast agents market, among procedures; cardiovascular disorders is expected to account for the largest share of the global contrast media/contrast agents market, among indications; and the radiology segment is expected to dominate the contrast media/contrast agents market, among applications.

In 2015, North America is estimated to be the largest market for contrast media/contrast agents, globally, followed by Europe, Asia-Pacific, and Rest of the World (RoW). In the coming years, the contrast media/contrast agents market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in this region can be attributed to the increasing research & development investments, expansion of international players, the increasing incidences of disease, and favorable regulatory frameworks.

The global contrast media/ contrast agents market has witnessed high competitive intensity in recent years, with Bayer Healthcare (Germany) and GE Healthcare (U.K.) being the leading market players. Other players include Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Mallinckrodt PLC (Ireland), and Lantheus Medical Imaging (U.S.), among others. The players in this market have implemented various strategies to expand their global footprint and increase their market shares. The key strategies followed by most of the companies in the contrast media market include agreements, partnerships, strategic alliances, collaborations, corporate alliances/contracts; market development; and expansions; among others.

[Reasons to Buy the Report]
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the contrast media/contrast agents market – the report analyzes the contrast media/contrast agents market, on the basis of product, route of administration, procedure, indication, and application

• Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, product approvals, and new product launches in the contrast media/contrast agents market

• Market Development: Comprehensive information about the lucrative emerging markets – the report analyzes the markets for various contrast media/contrast agents across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast media/contrast agents market

• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the contrast media/contrast agents market

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.3 Key Data From Secondary Sources
2.1.3.1 Primary Research
2.1.3.2 Key Industry Insights
2.1.4 Key Data From Primary Sources
2.1.5 Key Insights From Primary Sources
2.1.6 Market Size Estimation Methodology
2.1.7 Market Forecast Methodology
2.1.8 Market Data Validation and Triangulation
2.1.9 Assumptions

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Global Contrast Media/ Contrast Agents Market
4.2 Contrast Media/ Contrast Agents Market, By Product and Route of Administration
4.3 Contrast Media/ Contrast Agents Market, By Indication (2015 vs. 2020)

5 Market Overview (Page No. – 37)
5.1 Market Dynamics
5.2 Market Segmentation
5.2.1 Drivers
5.2.1.1 Increase in Demand for Diagnostics & Image Guided Procedures Influences the Sales of Contrast Media
5.2.1.2 Increasing Approvals for Contrast Agents
5.2.1.3 Increase in the Number of Public and Private Diagnostic Centers to Improve Diagnostic Imaging Services
5.2.1.4 Rising Number of Cancer Patients Responsible for Increasing the Number of Diagnostic Procedures
5.2.1.5 Increasing Prevalence of Diseases Associated With the Growth in the Aging Population is Driving the Demand of Various Diagnostic Imaging Modalities
5.2.1.6 Improving Healthcare Infrastructure in Emerging Markets
5.2.2 Restraints
5.2.2.1 Risk Associated With Contrast Agents
5.2.2.2 Need for Highly Skilled Professionals
5.2.3 Opportunities
5.2.3.1 Strong Product Pipeline Likely to Boost the Contrast Media Market
5.2.3.2 Increasing Research on Contrast Agent and Their Applications
5.2.4 Challenge
5.2.4.1 Development of Gamma and Neutron Imaging Solutions

6 Global Contrast Media/ Contrast Agents Market, By Product (Page No. – 52)
6.1 Introduction
6.2 Barium- Based Contrast Media
6.3 Iodinated Contrast Media
6.4 Gadolinium Based Contrast Media
6.5 Microbubbles

7 Global Contrast Media/ Contrast Agents Market, By Medical Procedure (Page No. – 62)
7.1 Introduction
7.2 X-Ray/CT
7.3 MRI
7.4 Ultrasound

8 Global Contrast Media/ Contrast Agents Market, By Route of Administration (Page No. – 70)
8.1 Introduction
8.2 Oral Contrast Media
8.3 Injectable Contrast Media
8.4 Rectal Contrast Media
8.5 Urethral Contrast Media

9 Global Contrast Media/ Contrast Agents Market, By Indication (Page No. – 78)
9.1 Introduction
9.2 Cardiovascular Disorders
9.3 Oncology
9.4 Gastrointestinal Disorders
9.5 Neurological Disorders
9.6 Nephrological Disorders
9.7 Musculoskeletal Disorders

10 Global Contrast Media/ Contrast Agents Market, By Application (Page No. – 87)
10.1 Introduction
10.2 Radiology
10.3 Interventional Radiology
10.4 Interventional Cardiology
10.5 Introduction
10.6 North America
10.6.1 U.S.
10.6.1.1 Increase in the Number of Diagnostic Imaging Centers
10.6.1.2 Increase in the Ageing Population and Rising Prevalence of Chronic Diseases in the U.S.
10.6.1.3 Reimbursement Cuts Under Obama Care
10.6.2 Canada
10.6.2.1 High Incidence Rate of Cancer, Cardiovascular Diseases and Diabetes in Canada
10.6.2.2 Increasing MRI and CT Examinations and Government Funding to Boost the Canadian Market
10.7 Europe
10.7.1 EU5
10.7.1.1 Increase in Investment By Market Players
10.7.1.2 Increasing Incidence and Prevalence of Cancer
10.7.1.3 Healthcare Spending Rises But Remains Weak in EU5 Countries
10.7.1.4 Shortage of Medical Imaging Instruments/Scanners Likely to Hamper the U.K. Market
10.7.2 RoE
10.7.2.1 Increase Focus of Market Players in RoE Countries
10.7.2.2 Increasing Number of MRI and CT Scanners
10.8 Asia-Pacific
10.8.1 Rise in the Ageing Population and Increasing Cancer Incidence
10.8.2 Rising Number of Diagnostic Facilities/Procedures in Japan
10.8.3 Expansion of International Players in China and India
10.8.4 Increasing R&D Investments in China
10.8.5 Favourable Regulatory Changes to Increase the Market in New Zealand and Australia
10.9 Rest of the World
10.9.1 Latin America
10.9.2 The Middle East
10.9.3 Africa

11 Competitive Landscape (Page No. – 136)
11.1 Overview
11.2 Market Share Analysis, Contrast Media/ Contrast Agents Market (2014)
11.2.1 Bayer Healthcare
11.2.2 GE Healthcare
11.3 Competitive Situation and Trends
11.3.1 Market Development (Product Approvals)
11.3.2 Agreements/ Collaborations/ Partnerships/ Strategic Alliances/ Contracts/ Corporate Alliances
11.3.3 Divestments /Investments
11.3.4 Expansions
11.3.5 Others

12 Company Profiles (Page No. – 150)
12.1 GE Healthcare
12.1.1 Business Overview
12.1.2 Financials
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.1.5 MnM View
12.2 Bayer Healthcare
12.2.1 Business Overview
12.2.2 Financials
12.2.3 Product Portfolio
12.2.4 Recent Developments
12.2.5 MnM View
12.3 Bracco Imaging S.P.A. (A Subsidiary of Bracco S.P.A.)
12.3.1 Business Overview
12.3.2 Financials
12.3.3 Product Portfolio
12.3.4 Recent Developments
12.3.5 MnM View
12.4 Guerbet Group
12.4.1 Business Overview
12.4.2 Financials
12.4.3 Product Portfolio
12.4.4 Recent Developments
12.4.5 MnM View
12.5 Mallinckrodt PLC
12.5.1 Business Overview
12.5.2 Financials
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.6 Lantheus Medical Imaging
12.6.1 Business Overview
12.6.2 Financials
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Nanopet Pharma Gmbh
12.7.1 Business Overview
12.7.2 Financials
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 CMC Contrast AB
12.8.1 Business Overview
12.8.2 Financials
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.9 Targeson, Inc. Pharma Co., Ltd.
12.9.1 Business Overview
12.9.2 Financials
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Daiichi Sankyo
12.10.1 Business Overview
12.10.2 Financials
12.10.3 Product Portfolio
12.10.4 Recent Developments
12.11 Subhra Pharma Private Limited
12.11.1 Business Overview
12.11.2 Financials
12.11.3 Product Portfolio
12.11.4 Recent Developments

13 Appendix (Page No. – 178)
13.1 Discussion Guide
13.2 Company Developments (2012-2015)
13.2.1 GE Healthcare
13.2.2 Bayer Healthcare
13.2.3 Bracco Imaging S.P.A.
13.3 Guerbet LLC
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (72 Figure)

Table 1 Increasing Demand for Diagnostics and Image Guided Procedures Coupled With Rising Number of Approvals for Contrast Agents/Media are Driving the Contrast Media/ Contrast Agents Market
Table 2 Risk Associated With Contrast Agents is A Major Factor Restraining the Growth of the Contrast Media/ Contrast Agents Market
Table 3 Strong Product Pipeline and Increasing Research Activities Influence the Growth of the Contrast Media/ Contrast Agents Market
Table 4 Development of Gamma and Neutron Imaging Solutions Pose as A Challenge in the Growth of the Contrast Media/ Contrast Agents Market
Table 5 Contrast Media/ Contrast Agents Market Size, By Product, 2015–2020 ($Million)
Table 6 Contrast Media/ Contrast Agents Market Size for Barium-Based Contrast Media, By Region, 2015–2020 ($Million)
Table 7 Contrast Media/ Contrast Agents Market Size for Iodinated Contrast Media, By Region, 2015–2020 ($Million)
Table 8 Contrast Media/ Contrast Agents Market Size for Gadolinium Based Contrast Media, By Region, 2015–2020 ($Million)
Table 9 Contrast Media/ Contrast Agents Market Size for Microbubble Contrast Media, By Region, 2015–2020 ($Million)
Table 10 Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020 ($Million)
Table 11 Contrast Media/ Contrast Agents Market Size for X-Ray/CT, By Region, 2015–2020 ($Million)
Table 12 Contrast Media/ Contrast Agents Market Size for MRI, By Region, 2015–2020 ($Million)
Table 13 Contrast Media/ Contrast Agents Market Size for Ultrasound, By Region, 2013–2020 ($Million)
Table 14 Contrast Media/ Contrast Agents Market Size, By Route of Administration, 2015–2020 ($Million)
Table 15 Contrast Media/ Contrast Agents Market Size for Oral Contrast Media, By Region, 2015-2020 ($Million)
Table 16 Contrast Media/ Contrast Agents Market Size for Injectable Contrast Media, By Region, 2015-2020 ($Million)
Table 17 Contrast Media/ Contrast Agents Market Size for Rectal Contrast Media, By Region, 2015-2020 ($Million)
Table 18 Contrast Media/ Contrast Agents Market Size for Urethral Contrast Media, By Region, 2015-2020 ($Million)
Table 19 Contrast Agents Market Size, By Indication, 2015-2020 ($Million)
Table 20 Contrast Agents Market Size for Cardiovascular Disorders, By Region, 2015-2020 ($Million)
Table 21 Market Size for Oncology , By Region, 2015-2020 ($Million)
Table 22 Market Size for Gastrointestinal Disorders, By Region, 2015-2020 ($Million)
Table 23 Market Size for Neurological Disorders, By Region, 2015-2020 ($Million)
Table 24 Market Size for Nephrological Disorders, By Region, 2015-2020 ($Million)
Table 25 Market Size for Musculoskeletal Disorders, By Region, 2015-2020 ($Million)
Table 26 Market Size, By Application, 2015–2020 ($Million)
Table 27 Market Size, By Applications, 2015–2020 ($Million)
Table 28 Market Size for Radiology, By Region, 2015-2020 ($Million)
Table 29 Market Size for Interventional Radiology, By Region, 2015-2020 ($Million)
Table 30 Market Size for Interventional Cardiology, By Region, 2015-2020 ($Million)
Table 31 Contrast Agents Market, By Region
Table 32 Contrast Agents Market Size, By Region, 2015–2020 ($Million)
Table 33 North America: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020 ($Million)
Table 34 North America: Market Size, By Product, 2015–2020($Million)
Table 35 North America: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 36 North America: Market Size, By Indication 2015–2020 ($Million)
Table 37 North America: Market Size , By Application 2015–2020 ($Million)
Table 38 U.S.: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 39 U.S: Market Size, By Product, 2015–2020($Million)
Table 40 U.S: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 41 U.S: Market Size By Indication 2015–2020 ($Million)
Table 42 U.S: Market Size By Application 2015–2020 ($Million)
Table 43 Canada: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 44 Canada: Market Size, By Product, 2013–2020($Million)
Table 45 Canada: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 46 Canada: Market Size, By Indication 2015–2020 ($Million)
Table 47 Canada: Market Size, By Application 2015–2020 ($Million)
Table 48 Europe: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 49 Europe: Market Size, By Product, 2015–2020($Million)
Table 50 Europe: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 51 Europe: Market Size, By Indication 2015–2020 ($Million)
Table 52 Europe: Market Size By Application 2015–2020 ($Million)
Table 53 EU5 : Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 54 EU5: Market Size, By Product, 2015–2020($Million)
Table 55 EU5: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 56 EU5: Market Size, By Indication 2015–2020 ($Million)
Table 57 EU5: Market Size , By Application 2015–2020 ($Million)
Table 58 RoE: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 59 RoE: Market Size, By Product, 2015–2020($Million)
Table 60 RoE: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 61 RoE: Market Size , By Indication 2015–2020 ($Million)
Table 62 RoE: Market Size , By Application 2015–2020 ($Million)
Table 63 APAC: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 64 APAC: Market Size, By Product, 2015–2020 ($Million)
Table 65 APAC: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 66 APAC: Market Size, By Indication 2015–2020 ($Million)
Table 67 APAC: Market Size, By Application 2015–2020 ($Million)
Table 68 RoW: Contrast Media/ Contrast Agents Market Size, By Procedure, 2015–2020($Million)
Table 69 RoW: Market Size, By Product, 2015–2020($Million)
Table 70 RoW: Market Size, By Route of Administration, 2015–2020 ($Million)
Table 71 RoW: Market Size, By Indication 2015–2020 ($Million)
Table 72 RoW: Market Size, By Application 2015–2020 ($Million)


List of Figures (38 Figures)

Figure 1 Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Market Forecast Methodology
Figure 7 Data Triangulation Methodology
Figure 8 Ultrasound Market to Witness the Highest CAGR of 19.3% From 2015 to 2020
Figure 9 The Injectable Route of Administration Segment is Expected to Continue to Dominate the Contrast Media Market in the Forecast Period
Figure 10 Asia-Pacific is Slated to Witness the Highest Growth in the Contrast Media Market in the Forecast Period
Figure 11 Market Overview
Figure 12 Injectable Contrast Media- the Contrast Agents Market in 2015
Figure 13 Asia to Witness Highest Growth Rate During the Forecast Period
Figure 14 Cardiovascular Disorders Commanded the Largest Share
Figure 15 Contrast Media Medical Imaging Market Segmentation
Figure 16 Drivers, Restraints, Challenge, & Opportunities
Figure 17 Microbubble Contrast Media is the Fastest Growing Product Segment of the Contrast Media/ Contrast Agents Market
Figure 18 X-Ray/CT Accounts for the Largest Share of the Contrast Media/ Contrast Agents Market
Figure 19 Injectable Contrast Media is the Largest and Fastest Growing Segment in the Contrast Media/ Contrast Agents Market
Figure 20 X-Ray/CT Accounts for the Largest Share of the Market
Figure 21 Interventional Radiology is Largest and Fastest Growing Application Segment in Contrast Media/Contrast Reagents Market
Figure 22 North America Commanded the Largest Share of Contrast Media/ Contrast Agents Market
Figure 23 U.S. Commanded the Largest Share of North American Contrast Media/ Contrast Agents Market
Figure 24 EU5 Region Dominates the European Contrast Media/ Contrast Agents Market
Figure 25 Market Development ( Product Approvals) Was the Key Growth Strategy for Market Players
Figure 26 Global Contrast Media/ Contrast Agents Market Share, By Key Player, 2014
Figure 27 Battle for Market Share: Market Development (Product Approvals)
Figure 28 Was the Key Strategy (2012-2015)
Figure 29 Key Players Focusing on Market Development (Product Approvals), 2012–2015
Figure 30 Key Players Focusing on Agreements/ Collaborations/ Partnerships/ Strategic Alliances/ Contracts /Corporate Alliances, 2012–2015
Figure 31 Key Players Focusing on Divestments/ Investments, 2012–2015
Figure 32 Key Players Focusing on Expansions, 2012–2015
Figure 33 Key Players Focusing on Other Strategies, 2012–2015
Figure 34 GE Healthcare: Company Snapshot
Figure 35 Bayer Healthcare: Company Snapshot
Figure 36 Guerbet Group: Company Snapshot
Figure 37 Mallinckrodt PLC: Company Snapshot
Figure 38 Lantheus Medical Imaging: Company Snapshot

【レポートのキーワード】

造影剤(コントラスト剤)、ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル(微小気泡)、X線検査、CT検査、MRI検査、超音波検査、医療、治療

★調査レポート[造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル] ( Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020 / MAM-MD-3577) 販売に関する免責事項
[造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル] ( Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020 / MAM-MD-3577) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆